Galera Therapeutics, Inc.
GRTX
$0.09
$0.00-4.61%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 149.04M | 149.05M | -8.99M | -13.18M | -16.17M |
| Total Depreciation and Amortization | -- | -- | 0.00 | 5.00K | 11.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -154.20M | -154.43M | 3.81M | 7.26M | 7.89M |
| Change in Net Operating Assets | 477.00K | -665.00K | -1.62M | -2.41M | -1.32M |
| Cash from Operations | -4.69M | -6.05M | -6.79M | -8.33M | -9.59M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | 3.50M | 3.50M | 0.00 | 4.00K | 4.00K |
| Cash Acquisitions | -- | -- | -50.00K | -50.00K | -50.00K |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 3.50M | 3.50M | -50.00K | -46.00K | -46.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 635.00K | 2.86M | 2.86M | 2.86M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 0.00 | 635.00K | 2.86M | 2.86M | 2.86M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.19M | -1.91M | -3.98M | -5.52M | -6.78M |